Wealth Effects’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,840
Closed -$206K 221
2024
Q3
$206K Buy
+1,840
New +$202K 0.07% 198
2024
Q2
Sell
-1,940
Closed -$213K 216
2024
Q1
$213K Buy
1,940
+1
+0.1% +$106 0.08% 193
2023
Q4
$201K Buy
+1,939
New +$187K 0.08% 208
2023
Q3
Sell
-2,189
Closed -$237K 200
2023
Q2
$237K Hold
2,189
0.1% 156
2023
Q1
$235K Hold
2,189
0.12% 160
2022
Q4
$238K Hold
2,189
0.14% 152
2022
Q3
$213K Hold
2,189
0.13% 154
2022
Q2
$226K Buy
2,189
+200
+10% +$21.5K 0.14% 155
2022
Q1
$228K Sell
1,989
-200
-9% -$22.4K 0.11% 171
2021
Q4
$272K Buy
+2,189
New +$262K 0.11% 161

Other funds holding FXH

Wealth Effects's FXH Position: Q4 2024 in Review

Wealth Effects sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q4 2024, closing a stake of 1,840 shares — an estimated $206K sold.

Wealth Effects first reported a position in FXH in Q4 2021 and held it in 10 quarters. The position peaked at $272K in Q4 2021. 252 funds tracked by Wall St. Rank hold FXH as of Q4 2024.

  • Wealth Effects reported no remaining First Trust Health Care AlphaDEX Fund position as of Q4 2024 after selling out during the quarter.
  • Wealth Effects sold 1,840 First Trust Health Care AlphaDEX Fund shares in Q4 2024, an estimated $206K.
  • Wealth Effects first reported a position in First Trust Health Care AlphaDEX Fund in Q4 2021 and held it in 10 quarters.
  • Wealth Effects's First Trust Health Care AlphaDEX Fund position peaked at $272K in Q4 2021.
  • 252 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q4 2024.

Based on Wealth Effects's 13F filing for Q4 2024, filed 22 Jan 2025.